William B. Bonello's most recent trade in Neogenomics Inc. was a trade of 5,727 Common Stock done at an average price of $7.5 . Disclosure was reported to the exchange on April 28, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neogenomics Inc. | William B. Bonello | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.52 per share. | 28 Apr 2022 | 5,727 | 191,548 (0%) | 0% | 7.5 | 43,067 | Common Stock |
| Neogenomics Inc. | William B. Bonello | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 5,727 | 0 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | William B. Bonello | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 82,305 | 185,821 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | William B. Bonello | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.52 per share. | 07 Mar 2022 | 5,000 | 103,516 (0%) | 0% | 7.5 | 37,600 | Common Stock |
| Neogenomics Inc. | William B. Bonello | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2022 | 5,000 | 5,727 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | William B. Bonello | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.29 per share. | 07 Mar 2022 | 3,209 | 98,516 (0%) | 0% | 18.3 | 58,693 | Common Stock |
| Neogenomics Inc. | William B. Bonello | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 99,772 | 99,772 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | William B. Bonello | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 40,869 | 102,742 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | William B. Bonello | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2022 | 620 | 101,725 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | William B. Bonello | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2022 | 397 | 102,345 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | William B. Bonello | President, Informatics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2021 | 21,400 | 61,873 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | William B. Bonello | President, Informatics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.52 per share. | 30 Nov 2021 | 25,000 | 40,473 (0%) | 0% | 7.5 | 188,000 | Common Stock |
| Neogenomics Inc. | William B. Bonello | President, Informatics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 25,000 | 10,727 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | William B. Bonello | President, Informatics | Sale of securities on an exchange or to another person at price $ 37.13 per share. | 24 Nov 2021 | 25,000 | 15,473 (0%) | 0% | 37.1 | 928,250 | Common Stock |
| Neogenomics Inc. | William B. Bonello | President, Informatics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2021 | 25,000 | 45,370 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | William B. Bonello | President, Informatics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.03 per share. | 24 Nov 2021 | 25,000 | 40,473 (0%) | 0% | 8.0 | 200,750 | Common Stock |
| Neogenomics Inc. | William B. Bonello | President, Informatics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 24,619 | 24,619 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | William B. Bonello | President, Informatics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 4,345 | 15,473 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | William B. Bonello | President, Informatics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2021 | 500 | 11,560 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | William B. Bonello | President, Informatics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2021 | 432 | 11,128 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | William B. Bonello | President, Informatics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2020 | 8,000 | 70,370 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | William B. Bonello | President, Informatics | Sale of securities on an exchange or to another person at price $ 46.80 per share. | 02 Dec 2020 | 8,000 | 12,060 (0%) | 0% | 46.8 | 374,400 | Common Stock |
| Neogenomics Inc. | William B. Bonello | President, Informatics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.03 per share. | 02 Dec 2020 | 8,000 | 20,060 (0%) | 0% | 8.0 | 64,240 | Common Stock |